Krzysztof Jamroziak graduated from the Faculty of Medicine, Medical University of Lodz in 1999. In the years 2001-2014 he was employed at the Department of Hematology, Medical University of Lodz, as a graduate student, assistant and tutor. From 2014 he serves as a head of the Department of Lymph Diseases of Institute of Hematology and Transfusion Medicine in Warsaw. Main research interests are focused on issues related to genetic factors, molecular prognostic factors and pharmacogenomics, as well as the individualization of hematological malignancies therapy, especially multiple myeloma and chronic lymphocytic leukemia. In addition, he is interested in the development of academic clinical studies in the field of Hematooncology in Poland. He is an author or a co-author of over 80 scientific articles in the field of hematology, including those published in the most prestigious hematological and oncological journals, such as Blood, Journal of Clinical Oncology, Leukemia, Haematologica, British Journal of Haematology. He is also actively involved in the work of Polish and foreign organizations engaged in scientific researches and standardization of hematological practice, such as the Polish Adult Leukemia Group (PALG), the Polish Myeloma Group (PGSz), the Polish Myeloma Consortium (PMC) and International Multiple Myeloma research (IMMEnSE). His scientific achievements has been awarded numerous awards, such as: award of the Minister of Science and Higher Education, the Minister of Science and Higher Education, the Ministry of Health, the Rector of the University of Lodz and the T. Michalski Foundation.